| Item Type | Name |
|
Concept
|
Lymphotoxin-alpha
|
|
Concept
|
Platelet-Derived Growth Factor
|
|
Concept
|
Receptors, Cell Surface
|
|
Concept
|
Receptors, Cholinergic
|
|
Concept
|
Receptors, GABA-A
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Receptors, Tumor Necrosis Factor
|
|
Concept
|
Receptors, Cytoplasmic and Nuclear
|
|
Concept
|
Receptors, Growth Factor
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Receptors, G-Protein-Coupled
|
|
Concept
|
Receptors, Nicotinic
|
|
Concept
|
Transforming Growth Factor alpha
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Glial Cell Line-Derived Neurotrophic Factor Receptors
|
|
Concept
|
Receptors, Adrenergic, beta
|
|
Concept
|
Receptors, Lysosphingolipid
|
|
Academic Article
|
Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytes.
|
|
Academic Article
|
PDGF upregulates delayed rectifier via Src family kinases and sphingosine kinase in oligodendroglial progenitors.
|
|
Academic Article
|
Trak1 mutation disrupts GABA(A) receptor homeostasis in hypertonic mice.
|
|
Academic Article
|
Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod.
|
|
Academic Article
|
Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.
|
|
Academic Article
|
Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.
|
|
Academic Article
|
Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.
|
|
Academic Article
|
FTY720 modulates human oligodendrocyte progenitor process extension and survival.
|
|
Academic Article
|
The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators.
|
|
Academic Article
|
Seronegative myasthenia gravis.
|
|
Academic Article
|
Signal transduction pathways in oligodendrocytes: role of tumor necrosis factor-alpha.
|
|
Academic Article
|
The beta 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats.
|
|
Academic Article
|
Depolarizing agents and tumor necrosis factor-alpha modulate protein phosphorylation in oligodendrocytes.
|
|
Academic Article
|
Beta-adrenergic modulation of K+ current in human T lymphocytes.
|
|
Academic Article
|
CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis.
|
|
Academic Article
|
IL-10 derived from CD1dhiCD5? B cells regulates experimental autoimmune myasthenia gravis.
|
|
Academic Article
|
S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination.
|
|
Academic Article
|
Impaired regulatory B cells in myasthenia gravis.
|
|
Academic Article
|
Regulation of cell cycle proteins by TNF-alpha and TGF-beta in cells of oligodendroglial lineage.
|
|
Academic Article
|
Tumor necrosis factor modulates the inactivation of catecholamine secretion in cultured sympathetic neurons.
|
|
Academic Article
|
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
|
|
Academic Article
|
Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells.
|
|
Academic Article
|
Cytokine-induced cell death in immortalized Schwann cells: roles of nitric oxide and cyclic AMP.
|
|
Academic Article
|
Tumor necrosis factor-alpha regulates nicotinic responses in mixed cultures of sympathetic neurons and nonneuronal cells.
|
|
Academic Article
|
Tumor necrosis factor modulates Ca2+ currents in cultured sympathetic neurons.
|
|
Academic Article
|
Myasthenia gravis induced by avelumab.
|
|
Academic Article
|
Modulation of immune responses by bile acid receptor agonists in myasthenia gravis.
|
|
Grant
|
Novel therapeutic targets in inflammatory neuropathies
|